Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
Acumen Pharmaceuticals (ABOS) Stock Price & Analysis
40 Followers
ABOS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.02 - $10.97
Previous Close$4.01
Volume39.39K
Average Volume (3M)80.26K
Market Cap
$172.30M
Enterprise Value-$27.77M
Total Cash (Recent Filing)$200.19M
Total Debt (Recent Filing)$133.00K
Price to Earnings (P/E)-3.8
Beta0.25
Next Earnings
May 15, 2023EPS Estimate
-$0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.05
Shares Outstanding40,925,284
10 Day Avg. Volume125,687
30 Day Avg. Volume80,258
Standard Deviation0.28
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.82
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda-0.66
Forecast
1Y Price Target
$16.67Price Target Upside315.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Acumen Pharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ABOS FAQ
What was Acumen Pharmaceuticals’s price range in the past 12 months?
Acumen Pharmaceuticals lowest stock price was $3.02 and its highest was $10.97 in the past 12 months.
What is Acumen Pharmaceuticals’s market cap?
Currently, no data Available
When is Acumen Pharmaceuticals’s upcoming earnings report date?
Acumen Pharmaceuticals’s upcoming earnings report date is May 15, 2023 which is in 47 days.
How were Acumen Pharmaceuticals’s earnings last quarter?
Acumen Pharmaceuticals released its earnings results on Mar 27, 2023. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.275 by -$0.045.
Is Acumen Pharmaceuticals overvalued?
According to Wall Street analysts Acumen Pharmaceuticals’s price is currently Undervalued.
Does Acumen Pharmaceuticals pay dividends?
Acumen Pharmaceuticals does not currently pay dividends.
What is Acumen Pharmaceuticals’s EPS estimate?
Acumen Pharmaceuticals’s EPS estimate is -$0.33.
How many shares outstanding does Acumen Pharmaceuticals have?
Acumen Pharmaceuticals has 41,025,063 shares outstanding.
What happened to Acumen Pharmaceuticals’s price movement after its last earnings report?
Acumen Pharmaceuticals reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.275. Following the earnings report the stock price went up 7.398%.
Which hedge fund is a major shareholder of Acumen Pharmaceuticals?
Among the largest hedge funds holding Acumen Pharmaceuticals’s share is RA Capital Management. It holds Acumen Pharmaceuticals’s shares valued at 53M.
---
Acumen Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.67 (315.71% Upside)
$16.67 (315.71% Upside)
Hedge Fund Trend
Decreased
By 461.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $59.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.94%
12-Months-Change
Fundamentals
Return on Equity
-20.71%
Trailing 12-Months
Asset Growth
-14.65%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Acumen Pharmaceuticals
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.
---
Top 5 ETFs holding ABOS
iShares Biotechnology ETF
Invesco Nasdaq Biotechnology ETF
Up to five ETFs with an Outperform Smart Score that hold ABOS. The ETFs are listed according to market value of ABOS within the ETF
---
---